We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL) (MEC ORL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01626638
Recruitment Status : Recruiting
First Posted : June 25, 2012
Last Update Posted : January 26, 2017
Sponsor:
Collaborator:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The primary objective is to validate the diagnostic correlation between the intraoperative microendoscopic images and the conventional histological analysis on biopsy and/or surgical specimens on patients with epidermoid carcinoma.

Condition or disease Intervention/treatment
Malignant Pharyngo Laryngeal Tumors Pre-malignant Pharyngo Laryngeal Tumors Procedure: Confocal Micro Endoscopy

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Clinical Evaluation of Confocal Microscopy in Head and Neck Cancer
Study Start Date : February 2013
Estimated Primary Completion Date : June 2018
Estimated Study Completion Date : June 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Experimental Procedure: Confocal Micro Endoscopy


Outcome Measures

Primary Outcome Measures :
  1. Diagnostic correlation between confocal micro endoscopy and conventional histology [ Time Frame: at an average of 18 months ]

Secondary Outcome Measures :
  1. Histological diagnostic with confocal micro endoscopy (MEC) VS conventional histological analysis [ Time Frame: At the time of the biopsy ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with malignant and pre-malignant pharyngo laryngeal tumors in whom direct laryngoscopy was performed under general anesthesia with biopsies for diagnostic or endoscopic removal
  • > 18 years
  • signed ICF

Exclusion Criteria:

  • Persons deprived of liberty
  • Patients with history of allergy to patent blue
  • Pregnant women or breastfeeding women
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01626638


Locations
France
Institut Gustave Roussy Recruiting
Villejuif, Val de Marne, France, 94805
Contact: Stéphane TEMAM, MD    +33 1 42 11 44 46      
Principal Investigator: Stéphane TEMAM, MD         
Sponsors and Collaborators
Gustave Roussy, Cancer Campus, Grand Paris
Ministry of Health, France
Investigators
Principal Investigator: Stéphane TEMAM, MD Gustave Roussy, Cancer Campus, Grand Paris
More Information

Responsible Party: Gustave Roussy, Cancer Campus, Grand Paris
ClinicalTrials.gov Identifier: NCT01626638     History of Changes
Other Study ID Numbers: 2011-A00818-33
First Posted: June 25, 2012    Key Record Dates
Last Update Posted: January 26, 2017
Last Verified: January 2017

Keywords provided by Gustave Roussy, Cancer Campus, Grand Paris:
Patients with malignant and pre-malignant pharyngo laryngeal tumors

Additional relevant MeSH terms:
Neoplasms
Head and Neck Neoplasms
Precancerous Conditions
Laryngeal Neoplasms
Neoplasms by Site
Otorhinolaryngologic Neoplasms
Laryngeal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Otorhinolaryngologic Diseases